As India is cementing Hyderabad’s position as the “Vaccine Capital of the World”, Biological E has announced its expansion plans for vaccine manufacturing with an overall investment of more than Rs 1,800 crore. This will provide job opportunities to more than 2,500 people in Genome Valley. The expansion is primarily […]
Read Time : 2 Minutes
Centre books 30 cr doses of second made-in-India Covid vaccine from Hyderabad-based Biological-E
The health ministry has finalised arrangements with Hyderabad-based vaccine manufacturer Biological-E to book 30 crore COVID-19 vaccine doses, set to be manufactured and stockpiled from August to December this year. As per a health ministry statement on Thursday, an advance payment of Rs 1,500 crore will be made to Biological-E from the Centre. […]